Liver disorder

Related records

Broader conditions (6)

• Digestive system disorder
• Disease
• Disease by body system or component
• Endocrine system disorder
• Hepatobiliary disorder
• Human disease

Narrower conditions (255)

• Aagenaes syndrome
• Acute hepatitis B virus infection
• Acute hepatitis C virus infection
• Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins
• Acute intermittent porphyria
• Acute liver failure
• Adenocarcinoma of gallbladder and extrahepatic biliary tract
• Adenosquamous bile duct carcinoma
• Adult hepatocellular carcinoma
• Aflatoxin-related hepatocellular carcinoma
• Alcoholic fatty liver disease
• Alcoholic hepatitis
• Alcoholic liver cirrhosis
• Alcoholic liver disease
• Ampulla of vater adenocarcinoma
• Ampulla of vater adenosquamous carcinoma
• Ampulla of vater cancer
• Ampulla of vater clear cell adenocarcinoma
• Ampulla of vater mucinous adenocarcinoma
• Ampulla of vater neoplasm

Trials (917)

• "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.
• "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
• 19 Versus 22-Gauge Needle for EUS-LB
• 3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection
• 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes
• 3D Liver Volumetry
• 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts
• 4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
• A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
• A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
• A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
• A Multi-Center Trial to Study Acute Liver Failure in Adults
• A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
• A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
• A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
• A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment
• A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease
• A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function
• A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Approved drugs (8)

• Avatrombopag maleate
• Cholic acid
• Cysteine hydrochloride
• Entecavir
• Gadoxetate disodium
• Givosiran sodium
• Metreleptin
• Tenofovir disoproxil fumarate

Drugs in development (264)

• Abiraterone acetate Phase 1
• Abrocitinib Phase 1
• Adafosbuvir Phase 1
• Ademetionine Phase 3
• Admilparant Phase 1
• Afatinib Phase 1
• Aldafermin Phase 1
• Alectinib Phase 1
• Alemtuzumab Phase 2
• Alisporivir Phase 2
• Alpelisib Phase 1
• Amlodipine Phase 2
• Apalutamide Phase 1
• Aprocitentan Phase 1
• Aumolertinib Phase 1
• Avacopan Phase 1
• Avatrombopag Phase 3
• Avenciguat Phase 1
• Balcinrenone Phase 1
• Bardoxolone methyl Phase 1

Other linked drugs (7)

• Acetylcysteine
• Azathioprine
• Dasatinib
• Defibrotide
• Ergocalciferol
• Ferumoxides
• Lactitol